Remibrutinib in Real-world Clinical Practice - a Germany Sub-study (REASSERT)
NCT07642557
·
clinicaltrials.gov ↗
RECRUITING
Status
470
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Spontaneous Urticaria
Sponsor
Novartis Pharmaceuticals